  {"id":43626,"date":"2020-06-04T11:00:31","date_gmt":"2020-06-04T02:00:31","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=43626"},"modified":"2020-06-05T12:20:22","modified_gmt":"2020-06-05T03:20:22","slug":"veeva-enables-cros-to-build-studies-faster-with-vault-edc","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/jp\/news\/veeva-enables-cros-to-build-studies-faster-with-vault-edc\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ\u3001Vault EDC\u3067CRO\u306e\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u3092\u8fc5\u901f\u5316"},"content":{"rendered":"<p style=\"text-align: center;\">\uff5e CRO\u4f01\u696d\u30c8\u30c3\u30d77\u793e\u4e2d5\u793e\u304cVault CDMS\u306eCRO\u30d1\u30fc\u30c8\u30ca\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u53c2\u52a0\u3001<\/p>\n<p style=\"text-align: center;\">\u8cea\u306e\u9ad8\u3044\u81e8\u5e8a\u8a66\u9a13\u3092\u8fc5\u901f\u5316 \uff5e<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\">2020\u5e746\u67084\u65e5<\/p>\n<p style=\"text-align: right;\">³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ) \u306f\u3001CRO \u304c<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-edc\/\">³Ô¹Ï±¬ÁÏ Vault EDC<\/a><\/strong>\u3092\u4f7f\u7528\u3057\u3066\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u3092\u8fc5\u901f\u5316\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3059\u308b\u3001\u65b0\u3057\u3044\u30d1\u30fc\u30c8\u30ca\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002CRO\u30d1\u30fc\u30c8\u30ca\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u4e00\u74b0\u3068\u3057\u3066\u3001\u30b9\u30bf\u30c7\u30a3\u306e\u69cb\u7bc9\u671f\u9593\u3092\u77ed\u7e2e\u3059\u308bVault EDC\u306e\u6700\u65b0\u30c7\u30b6\u30a4\u30f3\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3067\u3042\u308bStudio\u306b\u3088\u308a\u3001\u8a66\u9a13\u5b9f\u65bd\u8a08\u753b\u66f8\uff08\u30d7\u30ed\u30c8\u30b3\u30eb\uff09\u304b\u3089\u30b1\u30fc\u30b9\u30d6\u30c3\u30af\u3092\u76f4\u63a5\u4f5c\u6210\u3059\u308b\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3084\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u304cCRO\u306b\u63d0\u4f9b\u3055\u308c\u307e\u3059\u3002CRO\u5927\u624b\u30c8\u30c3\u30d77\u793e\u4e2d5\u793e\u3092\u542b\u308010\u793e\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u4f01\u696d\u304c\u3059\u3067\u306b\u3053\u306e<strong><a href=\"https:\/\/www.veeva.com\/jp\/meet-veeva\/partners\/cro\/\">\u30d7\u30ed\u30b0\u30e9\u30e0<\/a><\/strong>\u306b\u53c2\u52a0\u3057\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u306b\u5408\u308f\u305b\u3066\u30b9\u30bf\u30c7\u30a3\u3092\u69cb\u7bc9\u3057\u3066\u3044\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<strong><a href=\"https:\/\/www.veeva.com\/resources\/veeva-enables-cros-to-build-studies-faster-with-vault-edc\/\">\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n<p>&nbsp;<\/p>\n<p>Vault EDC\u306f\u3001\u30d7\u30ed\u30b0\u30e9\u30de\u30fc\u304c\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u69cb\u7bc9\u4e2d\u306b\u3001\u30d5\u30a9\u30fc\u30e0\u3084\u30b3\u30f3\u30dd\u30fc\u30cd\u30f3\u30c8\u3001\u30eb\u30fc\u30eb\u306a\u3069\u3092\u518d\u5229\u7528\u3057\u3084\u3059\u304f\u3059\u308b\u3053\u3068\u3067\u3001\u30b1\u30fc\u30b9\u30d6\u30c3\u30af\u4f5c\u6210\u306b\u304a\u3051\u308b\u7d20\u65e9\u3044\uff08\u30a2\u30b8\u30e3\u30a4\u30eb\uff09\u30c7\u30b6\u30a4\u30f3\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002CRO\u306f\u3001\u69cb\u7bc9\u30d7\u30ed\u30bb\u30b9\u4e2d\u306b\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u3088\u308a\u52b9\u679c\u7684\u306b\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u75c7\u4f8b\u5831\u544a\u66f8\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u4fee\u6b63\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u305d\u306e\u7d50\u679c\u3001\u30d7\u30ed\u30b0\u30e9\u30de\u30fc\u304c\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u69cb\u7bc9\u3059\u308b\u306e\u306b\u5fc5\u8981\u306a\u6642\u9593\u3068\u52b4\u529b\u306f\u5927\u5e45\u306b\u524a\u6e1b\u3055\u308c\u3001\u30c7\u30fc\u30bf\u53ce\u96c6\u958b\u59cb\u307e\u3067\u306e\u671f\u9593\u304c\u77ed\u7e2e\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u3053\u306eCRO\u30d1\u30fc\u30c8\u30ca\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u3088\u308a\u3001³Ô¹Ï±¬ÁÏ\u306fVault EDC\u3092\u4f7f\u7528\u3057\u3066\u30b1\u30fc\u30b9\u30d6\u30c3\u30af\u3092\u4f5c\u6210\u3059\u308b\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3092\u53d7\u3051\u305fCRO\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u62e1\u5927\u3055\u305b\u3066\u3044\u307e\u3059\u3002CRO\u306b\u306f2\uff5e4\u9031\u9593\u306e\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3001\u30a2\u30b8\u30e3\u30a4\u30eb\u30c7\u30b6\u30a4\u30f3\u306e\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u306b\u52a0\u3048\u3001\u30b1\u30fc\u30b9\u30d6\u30c3\u30af\u3092\u521d\u3081\u3066\u4f5c\u6210\u3059\u308b\u969b\u306e\u30e1\u30f3\u30bf\u30ea\u30f3\u30b0\u304c\u63d0\u4f9b\u3055\u308c\u307e\u3059\u3002\u307e\u305f\u3001CRO\u306fVault EDC\u3067\u8907\u96d1\u306a\u30b9\u30bf\u30c7\u30a3\u306e\u69cb\u7bc9\u3084\u8a66\u9a13\u5b9f\u65bd\u9014\u4e2d\u306e\u8a66\u9a13\u30c7\u30b6\u30a4\u30f3\u5909\u66f4\u3092\u7d20\u65e9\u304f\u884c\u3048\u308b\u3088\u3046\u3001\u5341\u5206\u306a\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3092\u53d7\u3051\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>³Ô¹Ï±¬ÁÏ\u306e<strong><a href=\"https:\/\/www.veeva.com\/jp\/roducts\/clinical-data-management\/\">³Ô¹Ï±¬ÁÏ Vault CDMS<\/a><\/strong>\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u30fb\u60a3\u8005\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u62c5\u5f53\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3067\u3042\u308bHenry Levy\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ\u306f\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u304c CRO\u306b\u6c42\u3081\u308b\u8cea\u306e\u9ad8\u3044\u30b9\u30bf\u30c7\u30a3\u306e\u69cb\u7bc9\u3084\u3001\u3088\u308a\u8fc5\u901f\u306a\u7acb\u3061\u4e0a\u3052\u3092\u5bb9\u6613\u306b\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002CRO \u304c³Ô¹Ï±¬ÁÏ Vault EDC\u3092\u5229\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u306f\u6700\u3082\u8907\u96d1\u306a\u30b9\u30bf\u30c7\u30a3\u306e\u69cb\u7bc9\u3084\u8a66\u9a13\u30c7\u30b6\u30a4\u30f3\u306e\u5909\u66f4\u3092\u304b\u3064\u3066\u306a\u3044\u307b\u3069\u8fc5\u901f\u306b\u884c\u3048\u308b\u3068\u3044\u3046\u78ba\u4fe1\u304c\u3082\u3066\u308b\u3088\u3046\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u3002\u300d<\/p>\n<p>\u3053\u306e\u307b\u304b\u306b\u3082\u3001³Ô¹Ï±¬ÁÏ\u306f\u3001\u30d0\u30fc\u30c1\u30e3\u30eb\u6765\u9662\u3068\u60a3\u8005\u4e2d\u5fc3\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u53ef\u80fd\u306b\u3059\u308b\u30de\u30eb\u30c1\u30c1\u30e3\u30cd\u30eb\u88ab\u9a13\u8005\u30dd\u30fc\u30bf\u30eb\u300c<strong><a href=\"https:\/\/www.veeva.com\/jp\/news\/veeva-announces-myveeva-to-enable-patient-centric-clinical-trials\/\">My³Ô¹Ï±¬ÁÏ<\/a><\/strong>\u300d\u3068\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u4e2d\u306b\u304a\u3044\u3066\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3092\u3064\u306a\u3050\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u300c<strong><a href=\"https:\/\/www.veeva.com\/jp\/news\/veeva-announces-vault-site-connect-to-automate-information-sharing-in-clinical-trials\">³Ô¹Ï±¬ÁÏ Vault Site Connect<\/a><\/strong>\u300d\u3092\u767a\u8868\u3057\u3066\u3044\u307e\u3059\u3002\u3044\u305a\u308c\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3082\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u30fb\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u30fb\u88ab\u9a13\u8005\u306e\u60c5\u5831\u5171\u6709\u3084\u95b2\u89a7\u3092\u53ef\u80fd\u306b\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u3092\u8fc5\u901f\u5316\u3059\u308b\u4e00\u9023\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u300c³Ô¹Ï±¬ÁÏ Clinical Network\u300d\u306e\u4e00\u90e8\u3067\u3059\u3002<\/p>\n<p>Vault EDC\u306f\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u3067EDC\u3001\u30b3\u30fc\u30c7\u30a3\u30f3\u30b0\u3001\u30c7\u30fc\u30bf\u30af\u30ec\u30f3\u30b8\u30f3\u30b0\u3001\u304a\u3088\u3073\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0\u3092\u7d71\u5408\u5316\u3059\u308b\u6700\u65b0\u306e\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u300c³Ô¹Ï±¬ÁÏ Vault CDMS\u300d\u306e\u4e00\u90e8\u3067\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: left;\"><strong>\u3010<\/strong><strong>³Ô¹Ï±¬ÁÏ Systems<\/strong><strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001850\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<a href=\"https:\/\/veeva.com\/jp\/\">https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>\u3010Forward-looking Statements\u3011<br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on F Form 10-K for the period ended January\u00a031, 2020. This is available on the company\u2019s website at <a href=\"https:\/\/www.veeva.com\/\">www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CRO\u4f01\u696d\u30c8\u30c3\u30d77\u793e\u4e2d5\u793e\u304cVault CDMS\u306eCRO\u30d1\u30fc\u30c8\u30ca\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u53c2\u52a0\u3002<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-43626","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43626"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=43626"}],"version-history":[{"count":5,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43626\/revisions"}],"predecessor-version":[{"id":43661,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43626\/revisions\/43661"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=43626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=43626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=43626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}